Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
March 3 (Reuters) - SynAct Pharma AB SYNACT.ST: SAID ON MONDAY CARRIED OUT DIRECTED ISSUE OF NEW SHARES OF ABOUT SEK 51.9 MLN SUBSCRIPTION PRICE WAS SET AT SEK 18.00 PER SHARE NET PROCEEDS WILL BE USED TO CREATE INCREASED FINANCIAL FLEXIBILITY, TO FUND EXTENSION OF RUNWAY TO SUPPORT POST-DATA PARTNERING DISCUSSIONS Source text for Workspace: nNDLcfs30x Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development